You report and you hope that some among us will take some action. Okay, we'll try to follow that up.
Let me ask about some of the high-cost new cancer therapies and biologic drugs that have been appearing on the market of late, not just here but internationally. Given that you rely on international comparisons, what are you doing at the international level to address these expensive treatments to keep them accessible for Canadians at the lowest cost?